Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03923790 · ClinicalTrials.gov registry record · NA

Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction

A NA study of Blood Pressure and Telemedicine, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT03923790: Completed NA study of Blood Pressure and Telemedicine, sponsored by The University of Texas Health Science Center, Houston.

NCT03923790 is a NA study of Blood Pressure and Telemedicine that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 83 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03923790, a NA study of Blood Pressure and Telemedicine, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot trial is to compare post-stroke care blood pressure (BP) treatment using an interdisciplinary telehealth model \[called the Stroke Telemedicine Outpatient Program (STOP) for Blood Pressure Reduction\] to usual care in stroke patients at risk for uncontrolled BP. The intervention will address general and stroke-related factors associated with racial disparities in BP control. We will assess feasibility of implementation of the trial and will use the measures and outcomes assessed in the pilot to examine knowledge gaps.

Primary Outcome

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Conditions Studied

Blood Pressure Telemedicine Psychosocial Impairment Stroke Prevention

Interventions

  • BEHAVIORAL Educational Packet
  • BEHAVIORAL Phone call at 72 hours by discharge nurse navigator
  • BEHAVIORAL Telehealth visit at 7 days, 1 month, 3 months, and 5 months after discharge
  • BEHAVIORAL Educational messages every other week
  • DIAGNOSTIC_TEST BP monitoring by QardioARM with periodic transmission of BP data

Study Locations (1)

Texas

  • University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2019-03-04
Est. Completion 2021-10-14
Phase NA
The University of Texas Health Science Center, Houston

732 total trials

What the finished NCT03923790 record still lists

NCT03923790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (71% lower).

The record links to 4 conditions, with Blood Pressure appearing as the primary indexed condition, and to 5 interventions - of which Educational Packet is the first listed.

NCT03923790 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03923790 about?

NCT03923790 is a clinical study titled "Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction". The purpose of this pilot trial is to compare post-stroke care blood pressure (BP) treatment using an interdisciplinary telehealth model \[called the Stroke Telemedicine Outpatient Program (STOP) for Blood Pressure Reduction\] to usual care in stroke patients at risk for uncontrolled BP. The interve...

What is the current status of trial NCT03923790?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2019-03-04. Estimated completion is 2021-10-14.

What conditions does trial NCT03923790 study?

This clinical trial studies the following conditions: Blood Pressure, Telemedicine, Psychosocial Impairment, Stroke Prevention.

What interventions are being tested in trial NCT03923790?

The interventions under investigation include: Educational Packet (BEHAVIORAL), Phone call at 72 hours by discharge nurse navigator (BEHAVIORAL), Telehealth visit at 7 days, 1 month, 3 months, and 5 months after discharge (BEHAVIORAL), Educational messages every other week (BEHAVIORAL), BP monitoring by QardioARM with periodic transmission of BP data (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03923790?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03923790 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03923790's enrollment target sits among peer trials

83 44th of 101 higher than 57 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03923790, the US trial registry maintained by the National Library of Medicine. NCT03923790 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.